Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-04 · accession 0002048497-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | 2026-03-04 | BBNX | Hopman Mark | Chief Commercial Off | S - Sale | $11.57 | -353 | 139.1K | -0.3% | -$4,084 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | S | D | 353 | $11.57 | 139,133 | D | — | — |